DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Brazil
  • /
  • Consumer Retailing
Author Program NEWCreate Narrative
PNVL3 logo

Dimed S.A. Distribuidora de Medicamentos Stock Price

BOVESPA:PNVL3 Community·R$1.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 15 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

PNVL3 Share Price Performance

R$12.69
3.12 (32.60%)
​
R$17.60
Fair Value
R$12.69
3.12 (32.60%)
27.9% undervalued intrinsic discount
R$17.60
Fair Value
Price R$12.69
AnalystConsensusTarget R$17.60
Fri, 19 Jun 26
Fair ValueR$17.60
Share Pricen/a

PNVL3 Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value R$17.6 27.9% undervalued intrinsic discount

Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
PNVL3 logo
Dimed Distribuidora de Medicamentos
27.9% undervalued intrinsic discount

Digital Strategy And AI Investments Will Improve Efficiency In Pharma Retail

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 19 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
PNVL3 logo

PNVL3: 2026 Extraordinary Meetings Will Support Bullish Repricing Case

Fair Value: R$17.6 27.9% undervalued intrinsic discount
11 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Reasonable growth potential with proven track record.

0 Risks
3 Rewards
View Full Analysis

Dimed S.A. Distribuidora de Medicamentos Key Details

R$5.9b

Revenue

R$3.9b

Cost of Revenue

R$1.9b

Gross Profit

R$1.8b

Other Expenses

R$137.7m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.92
33.04%
2.33%
46.6%
View Full Analysis

About PNVL3

Founded
1920
Employees
11426
CEO
Julio Mottin Neto
WebsiteView website
www.grupopanvel.com.br

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.

Recent PNVL3 News & Updates

Analysis Article • Aug 09

Dimed S.A. Distribuidora de Medicamentos Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

As you might know, Dimed S.A. Distribuidora de Medicamentos ( BVMF:PNVL3 ) last week released its latest...

Recent updates

No updates

Dimed S.A. Distribuidora de Medicamentos Competitors

RADL3 logo

Raia Drogasil

Symbol: BOVESPA:RADL3
Market cap: R$34.3b
ASAI3 logo

Sendas Distribuidora

Symbol: BOVESPA:ASAI3
Market cap: R$12.3b
GMAT3 logo

Grupo Mateus

Symbol: BOVESPA:GMAT3
Market cap: R$10.9b
PGMN3 logo

Empreendimentos Pague Menos

Symbol: BOVESPA:PGMN3
Market cap: R$2.7b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide